
Tamcool 0.4mg Tablet MR
Marketer
Tycoon Pharmaceuticals Pvt Ltd
Salt Composition
Tamsulosin (0.4mg)
Overview Tamcool 0.4mg Tablet MR
Alfuzosin 0.4mg modified-release tablets are alpha-blockers indicated for benign prostatic hyperplasia (BPH). They alleviate urinary symptoms such as hesitancy, but don't reduce prostate volume. Always adhere to your doctor's prescribed dosage and duration. This medication can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include dizziness, backache, chest discomfort, ejaculatory dysfunction, and retrograde ejaculation. Report persistent or bothersome side effects to your physician immediately. Simple lifestyle adjustments can aid symptom management. Void as soon as you feel the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Inform your doctor about all other medications before starting treatment. If undergoing cataract or glaucoma surgery, notify your ophthalmologist of Alfuzosin use. Patients with liver impairment should exercise caution, and schedule regular check-ups as directed by their physician.
Primary Ingredients of Tamcool 0.4mg Tablet MR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Tamcool 0.4mg Tablet MR
Managing benign prostatic hyperplasia
Major Benefits of Tamcool 0.4mg Tablet MR:
Consume this medication according to your doctor's prescribed dosage and timeframe. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Tamcool 0.4mg Modified-Release Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Tamcool 0.4mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamcool 0.4mg Tablet MR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tamcool 0.4mg Modified-Release Tablet can be consumed with or without food, although consistent timing is recommended.
How Tamcool 0.4mg Tablet MR works:
Tamcool MR 0.4mg tablets contain an alpha-blocking agent. By relaxing the bladder neck and prostate muscles, they facilitate smoother urine flow. This improves bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Tamcool 0.4mg MR tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Tamcool 0.4mg Tablet MR use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Tamcool 0.4mg Tablet MR while breastfeeding is likely unsafe. Available human data suggests potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Tamcool 0.4mg MR tablets.
KidneySAFE IF PRESCRIBED
Tamcool 0.4mg MR tablets are considered safe for patients with kidney impairment; dosage modification is generally unnecessary. Nevertheless, data regarding its use in individuals with end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tamcool 0.4mg MR tablets cautiously. Dosage modification of Tamcool 0.4mg MR tablets may be necessary; physician consultation is advised.
What if you forget to take Tamcool 0.4mg Tablet MR :
Should you forget a Tamcool 0.4mg Tablet MR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamcool 0.4mg Tablet MR
| Label | Value |
|---|---|
| Chemical Category | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
